Morgan Stanley discloses 8.4% stake in Klaviyo on Schedule 13G
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Morgan Stanley filed a Schedule 13G reporting beneficial ownership in Klaviyo, Inc. (KVYO) Series A Common Stock. The filing lists 10,321,920 shares beneficially owned, representing 8.4% of the class as of the 09/30/2025 event date. The firm reports 0 shares with sole voting or dispositive power, 6,785,764 shares with shared voting power, and 10,321,920 shares with shared dispositive power.
Morgan Stanley certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The reporting person is identified as a Delaware entity (Type: HC, CO), referencing CUSIP 49845K101. The issuer’s principal office is listed in Boston, MA.
Positive
- None.
Negative
- None.
FAQ
What stake did Morgan Stanley report in Klaviyo (KVYO)?
Morgan Stanley reported beneficial ownership of 10,321,920 shares, or 8.4% of Klaviyo’s Series A Common Stock.
What voting and dispositive powers were disclosed for KVYO?
Morgan Stanley disclosed 0 sole voting, 6,785,764 shared voting, 0 sole dispositive, and 10,321,920 shared dispositive power.
What is the Date of Event for Morgan Stanley’s 13G on KVYO?
The Date of Event is 09/30/2025.
What certification accompanies the 13G filing for KVYO?
It certifies the securities were acquired and are held in the ordinary course of business, not to change or influence control.
What class and CUSIP were reported for Klaviyo in this 13G?
The filing covers Series A Common Stock with CUSIP 49845K101.
Who is the reporting person and where are they organized?
The reporting person is Morgan Stanley, organized in Delaware (Type: HC, CO).